Todas las investigaciones
Inscripción por invitaciónOBSERVACIONAL

Registry of Patients With Hypophosphatasia

This is a long-term study collecting information from people of all ages who have Hypophosphatasia (HPP), a rare condition affecting bones and teeth. It's happening in different countries, including the UK. The main goal is to build a clearer picture of HPP – how it develops, what symptoms people experience, and how it impacts their lives. Researchers are also looking at how effective and safe a specific treatment called Asfotase alfa is for people with HPP. This study is observational, meaning participants are not given new treatments as part of the study; instead, information is collected about the care they are already receiving or would receive. It helps medical professionals better understand HPP and improve care for those living with it.

De un vistazo

Estado
Inscripción por invitación
Patrocinador
Alexion Pharmaceuticals, Inc.
Objetivo de inscripción
1,571
Inicio
20 Jan 2015
Estimación de finalización
31 Dic 2031

¿De qué trata este estudio?

This study is called a 'registry' for people with a rare condition known as Hypophosphatasia (HPP). HPP affects the development of bones and teeth, causing them to be softer and weaker than they should be. Because HPP is rare, doctors want to learn as much as possible about how it affects people over time, from babies to adults.

The registry is designed to follow people with HPP in the UK and other countries for many years. It's like building a large, detailed library of information about HPP. The researchers won't be giving new medicines or treatments as part of this study. Instead, they will gather details about people's health, their symptoms, how HPP has progressed, and what treatments they are receiving, including one called Asfotase alfa.

By collecting this information, doctors hope to gain a much better understanding of HPP. This will help them to improve how the condition is diagnosed, how it progresses, and ultimately, how to provide the best possible care and support for people living with it.

Puntos clave

  • It's a long-term study collecting information about Hypophosphatasia (HPP).
  • It aims to better understand HPP and its impact on people of all ages.
  • It observes outcomes for people receiving a treatment called Asfotase alfa.
  • No new treatments or extra appointments are involved.
  • Your medical care will not be affected by joining or leaving the study.
  • Your information helps improve future care for people with HPP.

¿Quién puede ser elegible?

To join this study, you must have a confirmed diagnosis of Hypophosphatasia (HPP). This diagnosis needs to be supported by a blood test showing low levels of a substance called alkaline phosphatase for your age and sex, or by a genetic test that identifies changes in the ALPL gene linked to HPP.

The study welcomes people of all ages, both male and female. If you are a child, your parent or legal guardian would need to agree for you to take part. All participants, or their legal representatives if they are unable, must be able to understand the study information and give their permission to join, either by reading or having it explained to them in their local language.

Essentially, if you or someone you care for has HPP and meets these basic requirements, you might be able to take part. However, you cannot join this study if you are already participating in another clinical trial sponsored by the company Alexion, though joining this registry won't stop you from participating in future trials they might run.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Do I have a confirmed diagnosis of Hypophosphatasia (HPP)?
  2. Is my alkaline phosphatase level below normal, or do I have a confirmed ALPL gene change?
  3. Am I (or my legal representative) able to understand study information?
  4. Am I not currently in another Alexion clinical trial?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you decide to join this study, you won't be given any new medication or experimental treatments. Instead, the study will simply collect information about your health as part of your regular medical care for HPP. This means researchers will gather details from your medical records regarding your HPP diagnosis, symptoms, how the condition has progressed over time, and any treatments you are receiving, specifically Asfotase alfa if applicable.

Participation is long-term, meaning information will be collected over many years. There are no extra visits or assessments specifically required for this study beyond what your doctors would normally do for your HPP care. You or your legal representative will be asked to sign an informed consent form and permission to share your medical records. The overall duration of your participation will depend on how long the registry continues to collect data and your willingness to remain involved.

Riesgos y beneficios potenciales

Taking part in this study does not involve any direct medical risks, as you won't be undergoing new tests or treatments for research purposes. The main benefit is that your information will contribute to a greater understanding of Hypophosphatasia, potentially improving diagnosis and treatment for others in the future. There is no direct personal medical benefit to you from being in this registry. You are free to withdraw from the study at any time without giving a reason, and this will not affect your medical care.

Locations (67)

  • Sitio de Investigación
    Código postal verificado
    Centennial, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Hartford, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Tampa, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Decatur, United States
  • Sitio de Investigación
    Código postal verificado
    Baltimore, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Boston, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Boston, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Minneapolis, United States
  • Sitio de Investigación
    Código postal verificado
    Kansas City, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    San Luis, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Hackensack, Estados Unidos
  • Sitio de Investigación
    Código postal verificado
    Mineola, Estados Unidos

Preguntas comunes

What is Hypophosphatasia (HPP)?

HPP is a rare condition that affects bones and teeth, making them softer and weaker than normal.

Is this study giving new medicine?

No, this study only collects information about your health and the care you are already receiving; it doesn't give new medications.

¿Cuánto tiempo estaré en el estudio?

This is a long-term study, so information will be collected over many years, following your regular care.

Do I have to attend extra appointments?

No, there are no extra appointments required specifically for this study beyond your usual medical care.

¿Puedo abandonar el estudio si cambio de opinión?

Yes, you can leave the study at any time, and it won't affect your medical care.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "Registry of Patients With Hypophosphatasia…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.